This report was first published by Endpoints News. To see the original version, click here
A diluted form of the Biosecure Act appears close to becoming law, after the House on Wednesday approved a defense bill that includes the measure.
Biosecure would restrict federal contracts with some Chinese biotech firms. Its advancement is notable after lawmakers declined to place it in last year’s defense package.
您已阅读22%（407字），剩余78%（1417字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。